Gut Microbiome and Mental Health: The Gut–Brain Axis in the Era

Authors

  • Eleni Siopi Assoc. Prof., Faculty of Fundamental and Biomedical Sciences, Université Paris Cité, Paris, France Author
  • Gwenola Le Dréan Assoc. Prof., INRAE, Microbiota-Gut-Brain Axis Group, University of Nantes, Nantes, France Author

Keywords:

Gut Microbiome, Gut–Brain Axis, Mental Health, Psychobiotics, Precision Medicine

Abstract

The human gut microbiome has emerged as an important component of the bidirectional communication network connecting the gastrointestinal tract and the central nervous system. Growing evidence suggests that alterations in microbial composition and metabolic activity may influence mental health through neural, endocrine, immune, and metabolic pathways. This narrative review examines current evidence concerning the microbiota–gut–brain axis, with particular emphasis on depression and anxiety, microbiome-mediated biological mechanisms, therapeutic interventions, and emerging applications in precision medicine. Relevant literature was identified through a structured PubMed search, prioritizing publications from 2023 to October 2026 alongside foundational studies. The reviewed evidence indicates that microbial metabolites, including short-chain fatty acids, tryptophan-derived compounds, and bile acids, may participate in neuroimmune regulation, intestinal barrier function, and stress-related signaling. Human observational and multi-omics studies have identified microbial and metabolic differences associated with depressive disorders, although findings remain heterogeneous and do not establish universal disease-specific microbial signatures. Probiotics, prebiotics, dietary interventions, and fecal microbiota transplantation have demonstrated varying degrees of therapeutic potential, but clinical findings remain inconsistent. Precision medicine approaches integrating microbial composition, functional pathways, metabolomic profiles, host characteristics, and lifestyle factors may improve patient stratification and intervention selection. However, standardized methods, validated biomarkers, and adequately powered longitudinal trials remain necessary before microbiome-guided mental healthcare can become routine clinical practice.

Downloads

Published

2026-05-15

Issue

Section

Articles

Similar Articles

You may also start an advanced similarity search for this article.